s125 most commonly adopted strategy to overcome lack of data availability, especially in the private healthcare setting, in which data are scarcer. Therefore, the aim of this study is to describe costs of cancer treatment and supportive care infusion of drugs used in breast cancer treatment in a cancer clinic of the private healthcare setting. Methods: We reviewed the claims of cancer treatment and supportive care infusions in breast cancer patients treated in UNICA clinic (private clinic from São Paulo, Brazil) from 2014-2018. After identifying breast cancer patients, we descriptively evaluated infusions per drug. Data were summarized by median (minimum -maximum).

No abstract

No abstract

No abstract